TotalMarketCap

Entrada Therapeutics

TRDANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$176.772 M

$4.54 -10.28%

Close of 6 Nov 2026

As of 6 Nov 2026, Entrada Therapeutics (TRDA) has a market capitalization of $176.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$25.4M

#2904 by revenue

Earnings

-$143.8M

Loss-making

Shares outstanding

39,150,334

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #251ProQR TherapeuticsPRQR$188.4M
  2. #252Keros TherapeuticsKROS$187.6M
  3. #253Entrada TherapeuticsTRDA$176.8M
  4. #254Natures Sunshine ProductsNATR$176.6M
  5. #255Upstream BioUPB$175.8M

What if Entrada Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$725,200.04

Per share 159,736× higher

Bitcoin $1.53T

$39,239.31

Per share 8,643× higher

Apple $5.02T

$128,819.00

Per share 28,374× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Entrada Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.